| scholarly article | Q13442814 |
| P2093 | author name string | Yuchen Zhang | |
| Hongming Liu | |||
| Xingwang Zhang | |||
| Baojian Wu | |||
| Shaohui Cai | |||
| P2860 | cites work | Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data. | Q33853860 |
| Block copolymer micelles for drug delivery: design, characterization and biological significance | Q34184381 | ||
| Hydrotropic Polymeric Mixed Micelles Based on Functional Hyperbranched Polyglycerol Copolymers as Hepatoma-Targeting Drug Delivery System | Q34468605 | ||
| Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study | Q36148584 | ||
| Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments | Q36730567 | ||
| Models of physiology and physiologically based models in clinical pharmacology | Q51353065 | ||
| Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles | Q51481527 | ||
| Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS). | Q54660067 | ||
| Identification of glucuronidation and biliary excretion as the main mechanisms for gossypol clearance: in vivo and in vitro evidence | Q57151091 | ||
| Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice | Q69746848 | ||
| Mixed micelles of Lecithin-Tyloxapol as pharmaceutical nanocarriers for anti-tubercular drug delivery | Q86926274 | ||
| Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation | Q87611453 | ||
| Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science | Q37790383 | ||
| Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion. | Q37820451 | ||
| Physiologically Based Pharmacokinetics Joined With In Vitro–In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology | Q38014312 | ||
| Why We Need Proper PBPK Models to Examine Intestine and Liver Oral Drug Absorption | Q38039233 | ||
| The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo | Q38054216 | ||
| Lipid emulsions in parenteral nutrition: current applications and future developments | Q38126971 | ||
| Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme | Q39099009 | ||
| Polymeric Mixed Micelles for Delivery of Curcumin to Multidrug Resistant Ovarian Cancer | Q39116595 | ||
| Enhanced antitumor efficacy by methotrexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancer. | Q39149669 | ||
| Mixed micelles of PEG2000-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: Enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines | Q39389498 | ||
| Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. | Q39429044 | ||
| Drug solubilization by amino acid based polymeric nanoparticles: Characterization and biocompatibility studies | Q39457578 | ||
| Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug | Q39599536 | ||
| Understanding and overcoming major barriers in cancer nanomedicine | Q41860837 | ||
| Modulator effects of meloxicam against doxorubicin-induced nephrotoxicity in mice. | Q42705756 | ||
| A versatile prodrug approach for liposomal core-loading of water-insoluble camptothecin anticancer drugs | Q44041221 | ||
| A miniature biofuel cell operating in a physiological buffer | Q44197840 | ||
| Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition | Q44786792 | ||
| Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles | Q44936086 | ||
| Novel drug release profiles from micellar solutions of PLA-PEO-PLA triblock copolymers | Q46968315 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 1625-1636 | |
| P577 | publication date | 2015-02-26 | |
| P1433 | published in | International Journal of Nanomedicine | Q6051502 |
| P1476 | title | Mixed nanomicelles as potential carriers for systemic delivery of Z-GP-Dox, an FAPα-based doxorubicin prodrug: formulation and pharmacokinetic evaluation | |
| P478 | volume | 10 |
| Q36137320 | Micellar emulsions composed of mPEG-PCL/MCT as novel nanocarriers for systemic delivery of genistein: a comparative study with micelles |
| Q59446927 | Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics |
| Q37573748 | Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells |
| Q38670397 | Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins |
Search more.